Trusynth Plus Neo

Trusynth Plus Neo


  • Triclosan coating – approved by WHO for SSI’s (Surgical Site Infections) management
  • Triclosan is effective against broad spectrum of pathogens including S. aureus, MRSA, E. coli
  • Triclosan – well-established safety profile
  • Substantial persistent antimicrobial activity due to its residual effect
  • Good knot security and easy knot placement


  • For soft tissue approximation
  • Mucosal closures
  • Skin closure
  • Dental surgery
  • Orthopedic surgery

The advanced braiding technology, smooth texture and Triclosan coating help avoid SSI. Trusynth Plus Neo is not recommended for use in cardiovascular and neurological tissues. This suture retains 60% of its initial tensile strength after 14 days and is absorbed by hydrolysis within 56 – 70 days of implantation.


  • Braided and coated polyglactin 910, coated with antibacterial agent Triclosan
  • Coating of calcium stearate and polyglactin 310
  • Available in undyed and violet colors
  • Sterilized by ethylene oxide
  • Shelf life of 5 years


  • USP sizes available : 4-0 to 2
  • Length available with needle: 35 cm to 185 cm
  • Needle length: 20 mm to 40 mm across all needle point profiles
We use cookies to ensure you get the best experience on our website. Click here to view cookie policy